Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Raymund Breu Ph.D.

Vice-Chairman, Member of Audit Committee and Member of Nomination & Compensation Committee, Nobel Biocare Holding AG
AgeTotal Calculated CompensationThis person is connected to 36 board members in 4 different organizations across 8 different industries.

See Board Relationships
69SFr.195,000

Background*

Dr. Raymund Breu, Ph.D. served as the Chief Financial Officer of Novartis AG from 1996 to February 1, 2010 and also its Executive Officer. Dr. Breu was an in charge of all finance activities and strategic planning of the Novartis Group. He served as Chief Financial Officer of Novartis Institutes for BioMedical Research, Inc., Novartis Group and Novartis Consumer Health, Inc. He joined the group treasury of Sandoz, a predecessor company of Novartis, in 1975. He was responsible ...

Read Full Background

Corporate Headquarters*

Balz Zimmermann-Strasse 7
Kloten, Zurich 8302

Switzerland

Phone: 41 43 211 42 00
Fax: 41 43 211 42 42

Board Members Memberships*

Director
Former Director and Member of Compensation Committee
Former Director and Member of Compensation Committee
1999-N/A
Former Director, Member of Compensation Committee, Member of Finance Committee and Member of Nominating and Corporate Governance Committee
2003-Present
Non-Executive Independent Director, Member of Audit Committee, Member of Investment Committee and Member of Finance & Risk Committee
2003-Present
Non-Executive Independent Director
2008-N/A
Director
2010-Present
Vice-Chairman, Member of Audit Committee and Member of Nomination & Compensation Committee

Education*

PhD 1975
Eidgenössische Technische Hochschule Zürich

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationSFr.115,000
Total Calculated CompensationSFr.195,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOBN:VX SFr.0.00 CHF 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Bret W. Wise Chairman, Chief Executive Officer and Chairman of Executive Committee
DENTSPLY International Inc.
$940.0K
David C. Dvorak Chief Executive Officer, President and Director
Zimmer Holdings, Inc.
$904.0K
Marco Gadola Chief Executive Officer and Member of Executive Management Board
Straumann Holding AG
SFr.1.6M
Kyoo-Ok Choi Chief Executive Officer and Director
Osstem Implant Co., Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOBEL BIOCARE HOLDING AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.